Moreover, several recent studies demonstrated that lack of AIM2 expression exhibited oncogenic properties and was closely associated with poor outcome in CRC [15–18], but the precise functional roles and underling mechanisms of AIM2 in CRC remain to be further explored. The gene discussed is AIM2; the disease is colorectal carcinoma.